총 278건 중 278건 출력
, 26/28 페이지
-
251
-
Knowledge, attitudes and practices towards antibiotic use in upper respiratory tract infections among patients seeking primary health care in Singapore
-
Pan, Darius Shaw Teng;
Huang, Joyce Huixin;
Lee, Magdalene Hui Min;
Yu, Yue;
Chen, Mark I-Cheng;
Goh, Ee Hui;
Jiang, Lili;
Chong, Joash Wen Chen;
Leo, Yee Sin;
Lee, Tau Hong;
Wong, Chia Siong;
Loh, Victor Weng Keong;
Poh, Adrian Zhongxian;
Tham, Tat Yean;
Wong, Wei Mon;
Lim, Fong Seng;
Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 119228 Singapore, Singapore;
Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 119228 Singapore, Singapore;
Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 119228 Singapore, Singapore;
Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 119228 Singapore, Singapore;
Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, 12 Science Drive 2, 117549 Singapore, Singapore;
Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, 12 Science Drive 2, 117549 Singapore, Singapore;
Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, 12 Science Drive 2, 117549 Singapore, Singapore;
(BMC family practice,
v.17,
2016,
pp.148)
-
252
-
Results from a Patient-Based Health Education Intervention in Reducing Antibiotic Use for Acute Upper Respiratory Tract Infections in the Private Sector Primary Care Setting in Singapore
-
Lee, Magdalene Hui Min;
Pan, Darius Shaw Teng;
Huang, Joyce Huixin;
Chen, Mark I-Cheng;
Chong, Joash Wen Chen;
Goh, Ee Hui;
Jiang, Lili;
Leo, Yee Sin;
Lee, Tau Hong;
Wong, Chia Siong;
Loh, Victor Weng Keong;
Lim, Fong Seng;
Poh, Adrian Zhongxian;
Tham, Tat Yean;
Wong, Wei Mon;
Yu, Yue;
Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
Saw Swee Hock School of Public Health, National University of Singapore, Singapore;
Saw Swee Hock School of Public Health, National University of Singapore, Singapore;
Saw Swee Hock School of Public Health, National University of Singapore, Singapore;
Saw Swee Hock School of Public Health, National University of Singapore, Singapore;
Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
Institute of Infectious Diseases and Epidemiology, Communicable Disease Centre, Tan Tock Seng Hospital, Singapore;
Institute of Infectious Diseases and Epidemiology, Communicable Disease Centre, Tan Tock Seng Hospital, Singapore;
Division of Family Medicine, Department of Medicine, University Medicine Cluster, National University Hospital S;
(Antimicrobial agents and chemotherapy,
v.61,
2017,
pp.e02257-16)
-
253
-
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients
-
Li, Chuan;
Phoon, Yee Peng;
Karlinsey, Keaton;
Tian, Ye F.;
Thapaliya, Samjhana;
Thongkum, Angkana;
Qu, Lili;
Matz, Alyssa Joyce;
Cameron, Mark;
Cameron, Cheryl;
Menoret, Antoine;
Funchain, Pauline;
Song, Jung-Min;
Diaz-Montero, C. Marcela;
Tamilselvan, Banumathi;
Golden, Jackelyn B.;
Cartwright, Michael;
Rodriguez, Annabelle;
Bonin, Christopher;
Vella, Anthony;
Zhou, Beiyan;
Gastman, Brian R.;
Department of Immunology, School of Medicine, University of Connecticut, Farmington, CT;
Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH;
Department of Immunology, School of Medicine, University of Connecticut, Farmington, CT;
Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH;
Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH;
Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH;
Department of Immunology, School of Medicine, University of Connecticut, Farmington, CT;
Department of Immunology, School of Medicine, University of Connecticut, Farmington, CT;
Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH;
Department of Nutrition, Case Western Reserve University, Cleveland, OH;
Department of Immunology, School of Medicine, University of Connecticut, Farmington, CT;
Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;
Taussig;
(The Journal of experimental medicine,
v.219,
2022,
pp.e20202084)
-
254
-
2409. Potential candidates for partial oral treatment in patients with endocarditis at a US center
-
Pries-Heje, Mia M;
Kim, Andy J;
Joyce, Mary-Ruth M;
Hartman, Dylan J;
Connolly, Erin M;
Itoh, Akinobu;
Cunningham, Mark;
O’Gara, Patrick;
Sun, Yee-Ping;
Maguire, James;
Aghayev, Ayaz;
Weber, Brittany N;
Di Carli, Marcelo;
Suzuki, Joji;
Ramirez, Yesenia Buenrostro;
Iversen, Kasper K;
Baden, Lindsey R;
Bundgaard, Henning;
Woolley, Ann E;
Rigshospitalet, University of Copenhagen , Copenhagen, Hovedstaden , Denmark;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women’s Hospital and Harvard Medical School , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital , Boston, Massachusetts;
Brigham and Women's Hospital / Harvard Medical School , Boston, MA;
Brigham and Women's Hospital , Boston, Massachusetts;
Herlev-Gentofte University Hospital, University of Copenhagen , Copenhagen, Hovedstaden , Denmark;
Brigham;
(Open forum infectious diseases,
v.10,
2023,
pp.ofad500.2029)
-
255
-
Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.
-
Schwartzberg, Lee S.;
Bondarenko, Igor;
Tolaney, Sara M.;
Seidman, Andrew David;
O'Shaughnessy, Joyce;
Shparyk, Yaroslav V.;
Chung, Chi-Feng;
Lu, Yen-Shen;
Chic, Nuria;
Panasci, Lawrence C.;
Chae, Yee Soo;
Recalde, Sabela;
Hotko, Yevhen;
Gomez, Patricia;
Wright, Gail Lynn Shaw;
Dacosta, Noshir Anthony;
Vatandoust, Sina;
O'Connell, Joseph P.;
Wei, Thomas;
Rugo, Hope S.;
West Cancer Center, Memphis, TN;
;
City Clinical Hospital No4, Dnipro, Ukraine;
;
Dana-Farber Cancer Institute, Boston, MA;
;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Texas Oncology-Baylor Sammons Cancer Center, US Oncology, Dallas, TX;
;
Lviv State Oncological Regional Medical and Diagnostic Center, Lviv, Ukraine;
;
Koo Foundation Sun Yat-sen Cancer Center, Taipei, Taiwan;
;
National Taiwan University Hospital, Taipei, Taiwan;
;
Hospital Clinic de Barcelona, Barcelona, Spain;
;
Jewish General Hospital, Montreal, QC, Canada;
;
Kyungpook National University Hospital, Daegu, South Korea;
;
Institut Catala d'Oncologia Hospital Duran i Reynals, Barcelona, Spain;
;
Uzhgorod National University, Uzhgorod, Ukraine;
;
Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;
;
Sarah Cannon Research Institute and Florida Cancer Specialists, New Port Richey, FL;
;
North Shore Hematology Oncology Associates, Stonybrook, NY;
;
Flinders Medical;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.39,
2021,
pp.1061-1061)
-
256
-
Morbidity Patterns in Primary Care in Hong Kong: Protocol for a Practice-Based Morbidity Survey (Preprint)
-
Chen Julie Yun;
Chao David;
Wong Samuel Yeung-shan;
Tse Tsui Yee Emily;
Wan Eric Yuk Fai;
Tsang Joyce Pui Yan;
Leung Maria Kwan Wa;
Ko Welchie;
Li Yim-chu;
Chen Catherine;
Luk Wan;
Dao Man-Chi;
Wong Michelle;
Leung Wing Mun;
Lam Cindy Lo Kuen;
;
(,
v.,
2022,
)
-
257
-
Effectiveness of a Two-Tier Family-Oriented Intervention in Enhancing the Family Functioning and Care Capacity of the Family Caregivers of Stroke Survivors: Protocol for a Randomized Controlled Trial
-
Lou, Vivian Weiqun;
Tang, Jennifer Yee Man;
Lau, Gary Kui Kai;
Lum, Terry Yat Sang;
Fong, Kenneth;
Ko, Rachel Wai Tung;
Cheng, Clio Yuen Man;
Fu, Joyce Yinqi;
Chow, Eddie Siu Lun;
Chu, Angus Chun Kwok;
Hui, Elsie;
Ng, Winnie Wing Ling;
Chan, Felix Hon Wai;
Luk, C C;
Kwok, T K;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Department of Medicine The University of Hong Kong Hong Kong Hong Kong;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Department of Rehabilitation Sciences The Hong Kong Polytechnic University Hong Kong Hong Kong;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Sau Po Centre on Ageing The University of Hong Kong Hong Kong Hong Kong;
Department of Medicine and Geriatrics Tuen Mun Hospital Hospital Authority Hong Kong Hong Kong;
Department of Medic;
(JMIR research protocols,
v.10,
2021,
pp.e16703)
-
258
-
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
-
Metcalf, Brian;
Chuang, Chihyuan;
Dufu, Kobina;
Patel, Mira P.;
Silva-Garcia, Abel;
Johnson, Carl;
Lu, Qing;
Partridge, James R.;
Patskovska, Larysa;
Patskovsky, Yury;
Almo, Steven C.;
Jacobson, Matthew P.;
Hua, Lan;
Xu, Qing;
Gwaltney, Stephen L.;
Yee, Calvin;
Harris, Jason;
Morgan, Bradley P.;
James, Joyce;
Xu, Donghong;
Hutchaleelaha, Athiwat;
Paulvannan, Kumar;
Oksenberg, Donna;
Li, Zhe;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Cytokinetics, Inc., South San Francisco, California 94080,;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Cytokinetics, Inc., South San Francisco, California 94080,;
Global Blood Therapeutics, Inc., South San Francisco, California 94080,;
Albert Einstein College of Medicine, Bronx, New York 10461,;
Albert Einstein College of Medicine, Bronx, New York 10461,;
Albert Einstein College of Medicine, Bronx, New York 10461,;
Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158,;
Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158,;
Global Blood Therapeutics, Inc., South San Fra;
(ACS medicinal chemistry letters,
v.8,
2017,
pp.321-326)
-
259
-
Next generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematologic malignancies
-
Hing, Zachary A.;
Fung, Ho Yee Joyce;
Ranganathan, Parvathi;
Mitchell, Shaneice;
El-Gamal, Dalia;
Woyach, Jennifer A.;
Williams, Katie;
Goettl, Virginia M.;
Smith, Jordan;
Yu, Xueyan;
Meng, Xiaomei;
Sun, Qingxiang;
Cagatay, Tolga;
Lehman, Amy M.;
Lucas, David M.;
Baloglu, Erkan;
Shacham, Sharon;
Kauffman, Michael G.;
Byrd, John C.;
Chook, Yuh Min;
Garzon, Ramiro;
Lapalombella, Rosa;
Medical Scientist Training Program, The Ohio State University, Columbus, OH, USA;
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, US;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, O;
(Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K,
v.30,
2016,
pp.2364-2372)
-
260
-
Copper-catalyzed asymmetric hydrogenation of 2-substituted ketones <i>via</i> dynamic kinetic resolution
-
Zatolochnaya, Olga
V.;
Rodrí
guez, Sonia;
Zhang, Yongda;
Lao, Kendricks S.;
Tcyrulnikov, Sergei;
Li, Guisheng;
Wang, Xiao-Jun;
Qu, Bo;
Biswas, Soumik;
Mangunuru, Hari P. R.;
Rivalti, Daniel;
Sieber, Joshua D.;
Desrosiers, Jean-Nicolas;
Leung, Joyce C.;
Grinberg, Nelu;
Lee, Heewon;
Haddad, Nizar;
Yee, Nathan K.;
Song, Jinhua J.;
Kozlowski, Marisa C.;
Senanayake, Chris H.;
Chemical Development , Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Old Ridgebury Road , Ridgefield , CT 06877 , USA . Email: yongda.zhang@boehringer-ingelheim.com;
Email: sonrodrod@hotmail.com;
Chemical Development , Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Old Ridgebury Road , Ridgefield , CT 06877 , USA . Email: yongda.zhang@boehringer-ingelheim.com;
Email: sonrodrod@hotmail.com;
Chemical Development , Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Old Ridgebury Road , Ridgefield , CT 06877 , USA . Email: yongda.zhang@boehringer-ingelheim.com;
Email: sonrodrod@hotmail.com;
Chemical Development , Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Old Ridgebury Road , Ridgefield , CT 06877 , USA . Email: yongda.zhang@boehringer-ingelheim.com;
Email: sonrodrod@hotmail.com;
Department of Chemistry , University of Pennsylvania , Philadelphia , PA 19104 , USA . Email: marisa@sas.upenn.edu;
Chemical Development , Boehringer Ingelheim Pharmaceuticals, Inc. , 900 Old Rid;
(Chemical science,
v.9,
2018,
pp.4505-4510)